Cargando…
Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer
BACKGROUND: Most previous reports to analyze risk factors for peritoneal recurrence in patients with colon cancer have been observational studies of a population-based cohort. OBJECTIVE: This study aimed to determine the risk factors for peritoneal recurrence in patients with stage II to III colon c...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012056/ https://www.ncbi.nlm.nih.gov/pubmed/29561282 http://dx.doi.org/10.1097/DCR.0000000000001002 |
_version_ | 1783333890087190528 |
---|---|
author | Mayanagi, Shuhei Kashiwabara, Kosuke Honda, Michitaka Oba, Koji Aoyama, Toru Kanda, Mitsuro Maeda, Hiromichi Hamada, Chikuma Sadahiro, Sotaro Sakamoto, Junichi Saji, Shigetoyo Yoshikawa, Takaki |
author_facet | Mayanagi, Shuhei Kashiwabara, Kosuke Honda, Michitaka Oba, Koji Aoyama, Toru Kanda, Mitsuro Maeda, Hiromichi Hamada, Chikuma Sadahiro, Sotaro Sakamoto, Junichi Saji, Shigetoyo Yoshikawa, Takaki |
author_sort | Mayanagi, Shuhei |
collection | PubMed |
description | BACKGROUND: Most previous reports to analyze risk factors for peritoneal recurrence in patients with colon cancer have been observational studies of a population-based cohort. OBJECTIVE: This study aimed to determine the risk factors for peritoneal recurrence in patients with stage II to III colon cancer who underwent curative resection. DESIGN: This was a pooled analysis using a combined database obtained from 3 large phase III randomized trials (N = 3714). SETTINGS: Individual patient data were collected from the Japanese Foundation for Multidisciplinary Treatment of Cancer clinical trials 7, 15, and 33, which evaluated the benefits of postoperative 5-fluorouracil–based adjuvant therapies in patients with locally advanced colorectal cancer. PATIENTS: We included patients who had stage II to III colon cancer and underwent curative resection with over D2 lymph node dissection. MAIN OUTCOME MEASURES: Main outcomes measured were risk factors for peritoneal recurrence without other organ metastasis after curative surgery. RESULTS: Peritoneal recurrence occurred in 2.3% (86/3714) of all patients undergoing curative resection. Mean duration from operation to peritoneal recurrence was 17.0 ± 10.3 months. Of these patients with peritoneal recurrence, 29 patients (34%) had recurrence in ≥1 other organ. Multivariate analysis showed that age (≥60 y: HR = 0.531; p = 0.0182), pathological T4 (HR = 3.802; p < 0.0001), lymph node involvement (HR = 3.491; p = 0.0002), and lymphadenectomy (D2: HR = 1.801; p = 0.0356) were independent predictors of peritoneal recurrence. The overall survival was lower in patients who developed peritoneal recurrence than in those with other recurrence (HR = 1.594; p = 0.002). LIMITATIONS: The regimens of adjuvant chemotherapy were limited to oral 5-fluorouracil. CONCLUSIONS: Our findings clarified the risk factors for peritoneal recurrence in patients who underwent curative resection for colon cancer. See Video Abstract at http://links.lww.com/DCR/A609. |
format | Online Article Text |
id | pubmed-6012056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Lippincott |
record_format | MEDLINE/PubMed |
spelling | pubmed-60120562018-07-03 Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer Mayanagi, Shuhei Kashiwabara, Kosuke Honda, Michitaka Oba, Koji Aoyama, Toru Kanda, Mitsuro Maeda, Hiromichi Hamada, Chikuma Sadahiro, Sotaro Sakamoto, Junichi Saji, Shigetoyo Yoshikawa, Takaki Dis Colon Rectum Original Contributions BACKGROUND: Most previous reports to analyze risk factors for peritoneal recurrence in patients with colon cancer have been observational studies of a population-based cohort. OBJECTIVE: This study aimed to determine the risk factors for peritoneal recurrence in patients with stage II to III colon cancer who underwent curative resection. DESIGN: This was a pooled analysis using a combined database obtained from 3 large phase III randomized trials (N = 3714). SETTINGS: Individual patient data were collected from the Japanese Foundation for Multidisciplinary Treatment of Cancer clinical trials 7, 15, and 33, which evaluated the benefits of postoperative 5-fluorouracil–based adjuvant therapies in patients with locally advanced colorectal cancer. PATIENTS: We included patients who had stage II to III colon cancer and underwent curative resection with over D2 lymph node dissection. MAIN OUTCOME MEASURES: Main outcomes measured were risk factors for peritoneal recurrence without other organ metastasis after curative surgery. RESULTS: Peritoneal recurrence occurred in 2.3% (86/3714) of all patients undergoing curative resection. Mean duration from operation to peritoneal recurrence was 17.0 ± 10.3 months. Of these patients with peritoneal recurrence, 29 patients (34%) had recurrence in ≥1 other organ. Multivariate analysis showed that age (≥60 y: HR = 0.531; p = 0.0182), pathological T4 (HR = 3.802; p < 0.0001), lymph node involvement (HR = 3.491; p = 0.0002), and lymphadenectomy (D2: HR = 1.801; p = 0.0356) were independent predictors of peritoneal recurrence. The overall survival was lower in patients who developed peritoneal recurrence than in those with other recurrence (HR = 1.594; p = 0.002). LIMITATIONS: The regimens of adjuvant chemotherapy were limited to oral 5-fluorouracil. CONCLUSIONS: Our findings clarified the risk factors for peritoneal recurrence in patients who underwent curative resection for colon cancer. See Video Abstract at http://links.lww.com/DCR/A609. Lippincott 2018-07 2018-03-20 /pmc/articles/PMC6012056/ /pubmed/29561282 http://dx.doi.org/10.1097/DCR.0000000000001002 Text en Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the ASCRS. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Original Contributions Mayanagi, Shuhei Kashiwabara, Kosuke Honda, Michitaka Oba, Koji Aoyama, Toru Kanda, Mitsuro Maeda, Hiromichi Hamada, Chikuma Sadahiro, Sotaro Sakamoto, Junichi Saji, Shigetoyo Yoshikawa, Takaki Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer |
title | Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer |
title_full | Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer |
title_fullStr | Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer |
title_full_unstemmed | Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer |
title_short | Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer |
title_sort | risk factors for peritoneal recurrence in stage ii to iii colon cancer |
topic | Original Contributions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012056/ https://www.ncbi.nlm.nih.gov/pubmed/29561282 http://dx.doi.org/10.1097/DCR.0000000000001002 |
work_keys_str_mv | AT mayanagishuhei riskfactorsforperitonealrecurrenceinstageiitoiiicoloncancer AT kashiwabarakosuke riskfactorsforperitonealrecurrenceinstageiitoiiicoloncancer AT hondamichitaka riskfactorsforperitonealrecurrenceinstageiitoiiicoloncancer AT obakoji riskfactorsforperitonealrecurrenceinstageiitoiiicoloncancer AT aoyamatoru riskfactorsforperitonealrecurrenceinstageiitoiiicoloncancer AT kandamitsuro riskfactorsforperitonealrecurrenceinstageiitoiiicoloncancer AT maedahiromichi riskfactorsforperitonealrecurrenceinstageiitoiiicoloncancer AT hamadachikuma riskfactorsforperitonealrecurrenceinstageiitoiiicoloncancer AT sadahirosotaro riskfactorsforperitonealrecurrenceinstageiitoiiicoloncancer AT sakamotojunichi riskfactorsforperitonealrecurrenceinstageiitoiiicoloncancer AT sajishigetoyo riskfactorsforperitonealrecurrenceinstageiitoiiicoloncancer AT yoshikawatakaki riskfactorsforperitonealrecurrenceinstageiitoiiicoloncancer |